Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome - Amrita Goyal, MD; Damodaran Narayanan, MBBS, PhD; Waihay Wong, MD, PhD; Alvaro C. Laga, MD; Nathan T. Connell, MD, MPH; Susan Y. Ritter, MD, PhD; Gabriela Cobos, MD (JAAD Case Reports, 2022)